Liver transplantation is a life-saving procedure that provides hope for individuals suffering from end-stage liver disease. However, recent studies have shed light on a concerning trend: liver transplant outcomes are significantly worse for Black patients compared to their counterparts from other racial backgrounds. This disparity highlights the urgent need to address systemic inequities within the healthcare system to ensure equitable access to transplantation and improve outcomes for all patients.
Black patients with hepatocellular carcinoma had lower rates of liver transplantation, as well as more complications and mortality when they did undergo a transplant, than other participants in a study of more than 112,000 patients, according to findings presented at the 2023 ASCO Annual Meeting.
According to the National Comprehensive Cancer Network, liver transplantation is currently the treatment of choice for patients with early HCC,” Fnu Vikash, MD, and colleagues wrote. “A retrospective study in 2016 showed a difference in mortality among races in patients undergoing treatment for HCC. Our study is the first to compare the outcomes of mortality, morbidity and hospital utilization of HCC patients undergoing [liver transplantation] among races in the US.”
Dr. Vikash and colleagues examined 2016-2020 data from the Nationwide Inpatient Sample and used multivariate regression analysis to compare outcomes across different races, adjusting for patient and hospital confounders. The researchers also compared baseline patient characteristics.
Black & Hispanic Patients Experience Worse Outcomes
The analysis included 112,110 adults with HCC. Among this group, 3,150 had a liver transplantation (2.8%).
Dr. Vikash and colleagues found that Black individuals had lower rates of liver transplantation, and both Black and Hispanic patients had lower income. While they observed no differences in the Charlson Comorbidity Index across races, they did report that there were more smokers among the group of Black patients (P=0.0149). Black patients also experienced greater rates of mortality (P=0.004) and acute kidney injury (P=0.001).
Hispanic patients incurred significantly higher hospital costs than White patients (coefficient: $102,058 [95% CI, $109,404-$119,787]; P=0.033). However, there was no difference reported between races regarding length of stay, and Black patients had similar rates of transplant complications compared with individuals of other races.
The Path to Equitable Transplantation:
Recognizing the alarming disadvantage faced by Black patients in liver transplant outcomes, healthcare professionals, policymakers, and researchers are increasingly focusing on addressing these disparities. Several strategies can be implemented to promote equitable transplantation:
Education and Awareness: Increasing cultural competency and awareness among healthcare providers can help reduce implicit biases in the transplant process. Improved understanding of the specific needs and challenges faced by Black patients can lead to more personalized and effective care.
Enhanced Outreach and Access: Implementing targeted outreach programs in underserved communities can facilitate early detection and management of liver diseases. Improving access to healthcare services, including liver transplantation centres, for marginalised populations is crucial in reducing disparities.
Organ Donation Advocacy: Efforts to increase organ donation rates, particularly within the Black community, can help alleviate the organ shortage and improve access to transplantation for all patients.
Research and Collaboration: Continued research into the root causes of disparities, as well as the development of evidence-based interventions, is essential. Collaborative efforts between healthcare institutions, researchers, and community organisations can drive meaningful change in addressing these disparities.
Conclusion:
The alarming disparity in liver transplant outcomes for Black patients highlights the urgent need to address systemic inequities within the healthcare system. By understanding the root causes, promoting education and awareness, enhancing outreach and access, advocating for organ donation, and fostering research collaboration, we can work towards achieving equitable liver transplant outcomes for all patients, regardless of their racial or ethnic background. It is imperative that we take collective action to ensure that every patient has an equal chance at receiving life-saving liver transplantation and achieving positive post-transplant outcomes.
